Connect Biopharma Holdings Ltd is trading at $2.37 (14.1% up) in pre-market as the stock stages a rebound following a recent stretch of weak closing prices.
- The move appears to be a technical recovery rather than a response to fresh catalysts, as no overnight headlines, earnings, FDA actions, or filings have been identified.
- Broader market strength may be supporting small-cap biotech sentiment, with major U.S. index futures trading higher ahead of the opening bell.